Brief: Canopy Growth And Spectrum Therapeutics Expand Medical Portfolio With New 30 And 90-Pack Softgels And Enhanced Dosing Options
07/05/2026 12:31
May 7 (Reuters) - Canopy Growth Corp WEED.TO: CANOPY GROWTH AND SPECTRUM THERAPEUTICS EXPAND MEDICAL PORTFOLIO WITH NEW 30 AND 90-PACK SOFTGELS AND ENHANCED DOSING OPTIONS Source text: ID:nBw6rhDH2a Further company coverage: WEED.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Canopy Growth
See all newsCanada's Canopy Growth Q4 revenue rises
Corrected: BRIEF-Canopy Growth Corp Q4 Revenue CAD 71.24 Million Vs. IBES Estimate CAD 74.4 Million
Brief: Canopy Growth Relaunches Tweed Brand In Germany With New Mtl Cannabis Strain Lineup, Marking First International Release Following Acquisition
Brief: Canopy Growth And Spectrum Therapeutics Expand Medical Portfolio With New 30 And 90-Pack Softgels And Enhanced Dosing Options
Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification